2023-06-21 16:36:58 ET
-
AlloVir ( NASDAQ: ALVR ) said Wednesday it plans to undertake a public offering of $75 million of its common stock.
-
Underwriters have a 30-day option to purchase up to an additional 15% of the shares being offered.
-
All of the shares in the proposed offering are to be sold by the company.
-
J.P. Morgan, Morgan Stanley, and BofA Securities are acting as joint book-running managers for the proposed offering.
-
The pricing details of the offering were not disclosed.
-
Shares -19.9% at $3.95 after hours.
For further details see:
AlloVir plans for $75M stock offering